The Changing Oncology Landscape: Evolution or Revolution?

被引:3
作者
Beveridge, Roy [1 ,2 ,3 ]
Fox, John
Higgins, Susan A. [4 ,5 ,6 ]
Kohn, Martin [7 ]
Mahoney, John J. [8 ]
Newcomer, Lee N. [9 ,10 ]
von Eschenbach, Andrew [11 ,12 ]
机构
[1] US Oncol, The Woodlands, TX USA
[2] US Oncol Network, The Woodlands, TX USA
[3] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Div Obstet & Gynecol, New Haven, CT 06520 USA
[5] Smilow Canc Hosp, Multidisciplinary Gynecol Dis Team Unit, New Haven, CT USA
[6] Therapeut Radiol Residency Training Program, New Haven, CT USA
[7] Pitney Bowes Inc, Stamford, CT USA
[8] UnitedHlth Grp, Minneapolis, MN USA
[9] Pk Nicollet Hlth Serv, St Louis Pk, MN USA
[10] Samaritan Hlth Initiat Inc, Montgomery, TX USA
[11] US FDA, Rockville, MD 20857 USA
[12] NCI, Bethesda, MD 20892 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2013年 / 11卷 / 5.5期
关键词
D O I
10.6004/jnccn.2013.0190
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Complex challenges face all players in the oncology landscape, from health care policy leaders and third-party payers, to practicing physicians and nurses, to patients and their families. In these unsteady economic times, possible answers proposed by some may represent part of the problem to others. A distinguished panel assembled at the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care to explore the changing oncology landscape. This article is the synopsis of that discussion, with panelists shedding light on such issues as the astronomic cost of medical care, the need for clinicians to think outside the formulary, and the therapeutic decision-making process in the new world of "big data."
引用
收藏
页码:636 / 638
页数:3
相关论文
empty
未找到相关数据